Want to see TSE:IAN full AI Analyst Report?
Top Page
iAnthus Capital Holdings
(IAN)
Select Model
Select Model
Rating:41Neutral
Price Target:
C$0.01
▲(0.00% Upside)
Action:Upgraded
Date:08/17/26
The score is primarily driven down by weak financial performance (sharp revenue contraction, persistent losses, negative equity, high leverage, and renewed cash burn). With limited/no technical indicator data and a negative P/E alongside no dividend yield, there are few offsetting positives from technicals or valuation.
Positive Factors
Licensed Cannabis Platform
The company has historically operated across multiple licensed cannabis activities, providing vertical capabilities from cultivation through retail. This platform can support product control and market access if restructuring restores operational continuity.
Negative Factors
Severe Revenue Contraction
A sharp and sustained top-line decline weakens operating leverage, reduces the company’s ability to absorb fixed costs, and can erode market presence. Recovery would require renewed demand, stable operations, and successful execution across its regulated markets.
Read all positive and negative factors
Positive Factors
Negative Factors
Licensed Cannabis Platform
The company has historically operated across multiple licensed cannabis activities, providing vertical capabilities from cultivation through retail. This platform can support product control and market access if restructuring restores operational continuity.
Read all positive factors
iAnthus Capital Holdings (IAN) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$34.87M
Dividend YieldN/A
Average Volume (3M)141.69K
Price to Earnings (P/E)―
Beta (1Y)-1.35
Revenue Growth-11.58%
EPS Growth-1950.00%
CountryCA
Employees741
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding6,974,811,000
10 Day Avg. Volume66,308
30 Day Avg. Volume141,689
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.24
Price to Sales (P/S)0.17
P/FCF Ratio-1.16
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
iAnthus Capital Holdings Business Overview & Revenue Model
Company Description
iAnthus Capital Holdings, Inc. is a U.S.-based cannabis enterprise that holds licenses for and actively manages cannabis cultivation, processing, and retail dispensary operations. Its diverse product portfolio encompasses both cannabis and cannabi...
How the Company Makes Money
null...
iAnthus Capital Holdings Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
12
Very Negative
Cash Flow
16
Very Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 140.60M | 146.51M | 167.57M | 159.24M | 163.21M | 203.02M |
| Gross Profit | 34.35M | 47.22M | 75.11M | 63.17M | 74.43M | 111.28M |
| EBITDA | -8.75M | 5.04M | 21.22M | -2.59M | -369.80M | 7.89M |
| Net Income | -55.46M | -40.91M | -7.64M | -76.62M | -449.39M | -76.25M |
Balance Sheet | ||||||
| Total Assets | 258.00M | 275.19M | 271.04M | 277.41M | 303.47M | 346.74M |
| Cash, Cash Equivalents and Short-Term Investments | 8.26M | 11.85M | 18.54M | 13.10M | 14.34M | 13.24M |
| Total Debt | 238.68M | 227.54M | 210.46M | 201.00M | 183.94M | 228.54M |
| Total Liabilities | 388.54M | 378.05M | 336.58M | 339.07M | 292.48M | 369.14M |
| Stockholders Equity | -130.54M | -102.85M | -65.54M | -61.67M | 10.99M | -22.40M |
Cash Flow | ||||||
| Free Cash Flow | -22.61M | -20.99M | 7.03M | -3.06M | -26.55M | -4.25M |
| Operating Cash Flow | -1.33M | 3.20M | 12.54M | 3.02M | -19.50M | 16.15M |
| Investing Cash Flow | -10.43M | 2.34M | -6.28M | -3.63M | -4.74M | -21.32M |
| Financing Cash Flow | -3.88M | -12.89M | -339.00K | -618.00K | 22.06M | 10.24M |
iAnthus Capital Holdings Risk Analysis
iAnthus Capital Holdings disclosed 67 risk factors in its most recent earnings report. iAnthus Capital Holdings reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
iAnthus Capital Holdings Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | C$2.34B | 14.18 | 6.82% | ― | 3.81% | 344.13% | |
53 Neutral | C$3.63B | -72.59 | -4.47% | ― | 1.50% | 81.84% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | C$2.17B | -1.69 | -35.22% | ― | -2.30% | 26.63% | |
45 Neutral | C$493.18M | -2.51 | -28.27% | ― | -5.83% | -115.39% | |
41 Neutral | C$34.87M | -0.57 | 50.32% | ― | -11.58% | -1950.00% |
* Healthcare Sector Average
TSE:IAN
iAnthus Capital Holdings
0.01
0.00
0.00%
TSE:CURA
Curaleaf Holdings
13.74
0.87
6.76%
TSE:GTII
Green Thumb Industries
10.66
-1.22
-10.27%
TSE:CL
Cresco Labs
1.06
-0.64
-37.65%
TSE:VRNO
Verano Holdings
6.32
0.00
0.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.